脓毒性休克中血管加压药累积剂量需求与早期死亡风险:EPISS队列分析
该研究为EPISS试验的子研究,基于2009至2011年法国ICU收治的370例脓毒性休克患者,评估血管加压药累积剂量(CDV,即肾上腺素与去甲肾上腺素累积剂量之和)是否为72小时内归因于难治性脓毒性休克的早期死亡(EDASS)的预测指标。370例中51例(14%)在72小时内死亡,其中40例(11%)为EDASS。基于6小时CDV≥800 μg/kg和/或24小时CDV≥2,600 μg/kg的两步策略预测EDASS的敏感度45%、特异度97%、阳性预测值78%、阴性预测值94%。作者认为早期死亡可被治疗最初数小时的CDV有效预测,有助于筛选适合创新疗法的患者。
要点
- 370例脓毒性休克患者中,72小时内死亡51例(14%),归因于难治性脓毒性休克的早期死亡(EDASS)40例(11%)。
- 两步预测策略:6小时CDV≥800 μg/kg和/或24小时CDV≥2,600 μg/kg,预测EDASS敏感度45%、特异度97%。
- 该策略阳性预测值78%、阴性预测值94%,阴性预测值高有助于排除EDASS高风险。
- CDV为肾上腺素与去甲肾上腺素累积剂量之和,在治疗最初数小时即可计算。
- 作者认为CDV可有效预测早期死亡,有助于筛选适合针对早期死亡率创新疗法的患者。
适用人群与场景
- 2009至2011年法国ICU收治的脓毒性休克患者,共370例。
诊断标准与关键阈值
- CDV定义为肾上腺素累积剂量与去甲肾上腺素累积剂量之和。
- 两步预测策略:6小时CDV≥800 μg/kg和/或24小时CDV≥2,600 μg/kg。
研究设计与关键结果
- 研究类型为EPISS试验的子研究,样本量370例,人群为法国ICU脓毒性休克患者。
- 主要终点:72小时内归因于难治性脓毒性休克的早期死亡(EDASS);370例中51例(14%)72小时内死亡,其中40例(11%)为EDASS。
- 在血管加压药启动后6、12、24、36、48小时计算CDV的受试者工作特征曲线下面积,并基于所选时间点和阈值构建EDASS风险预测策略。
- 两步策略(6小时CDV≥800 μg/kg和/或24小时CDV≥2,600 μg/kg)预测EDASS:敏感度45%、特异度97%、阳性预测值78%、阴性预测值94%。
证据类型、等级与局限
- 证据类型:EPISS试验的子研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,早期死亡可直接归因于脓毒性休克,并可由治疗最初数小时的CDV有效预测。
- 作者认为,这些结果将有助于筛选适合针对改善脓毒性休克早期死亡率的创新疗法的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Septic shock is the primary cause of death in intensive care units, with about 20% of patients dying in the first 3 days. To design future trials focused on early mortality, we require knowledge of early indicators that can detect patients at high risk of early death from refractory septic shock. The aim of this study was to assess whether the cumulative dose of vasopressors (CDV), calculated as the cumulative dose of epinephrine + norepinephrine, is a predictor of early death (within 72 h) attributable to refractory septic shock (EDASS). This substudy of the EPISS trial was based on 370 patients admitted to a French ICU for septic shock between 2009 and 2011. The area under the receiving operating characteristic curve was calculated for the CDV at 6, 12, 24, 36, and 48 h after vasopressor initiation, and a strategy to predict the risk of EDASS was built based on selected times and thresholds. Among the 370 patients included, 51 (14%) died within the first 72 h with 40 (11%) EDASS. A strategy in two steps (CDV ≥ 800 μg/kg at 6 h and/or CDV ≥ 2,600 μg/kg at 24 h) was able to predict EDASS with sensitivity of 45%, specificity 97%, positive predictive value 78% and negative predictive value 94%. Overall, our results confirm that early death directly attributable to septic shock could be effectively predicted by the CDV in the first hours of treatment. These results will help to select patients eligible for innovative therapies aimed at improving early mortality in septic shock.
参考来源
- Dargent A, Nguyen M, Fournel I, et al. Vasopressor Cumulative Dose Requirement and Risk of Early Death During Septic Shock: An Analysis From The EPISS Cohort. Shock. 2018. PMID: 29040212. doi:10.1097/SHK.0000000000001022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。